Isomorphic Labs
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
$2.1BSeries B
Role not disclosedA
Alphabet
Activity from announced rounds
Activity in this selectionprotein-capital-76af7244
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $2.1B 1 disclosed · full round size, not this investor’s share